University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Location status: Recruiting
NCT Number: NCT06217588
The purpose of the LCAT (Lecithin cholesterol acyl transferase) Natural History Study (LCAT NHS) is to help identify people with a mutation in a gene called LCAT, collect and store information about their medical history and disease course, and to assess for associations and follow changes in clinical features and biomarkers of disease. This information will help health care providers better understand the natural history of disease of LCAT deficiency.
Study staff will collect information from previous clinical visits such as lab tests, physical exam findings, renal and cardiovascular imaging, findings from kidney biopsies and eye exams, and medication and other treatments. As part of this study the investigators are asking participants permission to reach out to their doctors to obtain medical records and stored samples (such as serum or plasma or biopsies) from past visits.
Participants may also be asked to join a web-based patient portal to complete a patient-outcomes survey.
As part of this study, participants will also be asked to do the following things at different times:
* Answer questions about: * Demographic information (year of birth, age, gender, race/ethnicity, country) * LCAT deficiency diagnosis such as year of diagnosis, type of diagnosis (clinical, genetic), genotype information/LCAT mutation status * Medical history and family history and any updates * A review of medications
If participants are able to come to a study visit in person the following may happen:
Physical examination including vital signs (height, weight, blood pressure, and heart rate) Urine and blood samples for laboratory testing. participants will be required to fast for 10 hours before the blood tests. A small blood sample may also be taken 2-4 hours after a meal.
* The following will be tested: the different types of cholesterol and other fats in the blood (lipids), standard hematology (type and number of blood cells), blood chemistries such as sodium, potassium, and calcium, thyroid function, liver panel (function of the liver), kidney function and the level of protein in urine * Blood and urine samples may also be stored for future testing * Genetic material will be collected * Blood cells may be stored for future research * Participants will have approximately 4.5 tablespoons of blood drawn annually. * If not done previously, participants will complete an eye exam. * Participants may be seen by a doctor specialized in renal disease
Interested in participating?
Request InfoAll sexes
Observational
Philadelphia, Pennsylvania, 19104, United States
Location status: Recruiting
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The study will collect extensive historical health data (retrospective), and at baseline will conduct an extensive characterization of the disease progression using the parameters described above.
Time frame: Through study completion, an average of 4 years
Outreach efforts will be made to reach a total of study 40 participants
Time frame: Through study completion, an average of 4 years
The investigators will determine the mean age of diagnosis of LCAT Deficiency
Time frame: Through study completion, an average of 4 years
The investigators will assess the average time it takes to develop chronic kidney disease
Contact information is provided by the study sponsor or research team.
Gregory Alfaro
CONTACT
Marina Cuchel, MD, PhD
CONTACT
University of Pennsylvania
Other
LCAT Deficiency Disorders: Natural History and Identification of Biomarkers
Acronym: LCAT NHS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06907147
Cardiovascular Diseases, Chronic Disease
Stanford, California, United States
View Trial DetailsNCT06625073
Cardiovascular Disease, Cardiovascular Diseases
Palo Alto, California, United States
View Trial DetailsNCT06966258
Behavior, Body Weight
Birmingham, Alabama, United States
View Trial DetailsNCT02770066
Arterial Occlusive Diseases, Cardiovascular Diseases
Aalborg, Denmark
View Trial Details